Natascha Jeffries
Family · Belleville, ILNPI 1629409362
Payments from drug & device makers
Across 404 payments — averaging $27.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$4K
- Gilead$2K
- Johnson & Johnson$2K
- AbbVie$732
- Novo Nordisk$707
- Merck$570
- plus $2K from 22 others
What the payments were for
- Food & beverage$10,88199%
- Education$991%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 143 | $3,651 |
| Gilead | 71 | $2,029 |
| Johnson & Johnson(2 entities) | 48 | $1,505 |
| AbbVie | 34 | $732 |
| Novo Nordisk | 27 | $707 |
| Merck | 23 | $570 |
| Janssen Scientific Affairs, LLC | 5 | $481 |
| Theratechnologies Inc. | 13 | $308 |
| Teva Pharmaceuticals USA, Inc. | 1 | $104 |
| AstraZeneca | 1 | $100 |
| Janssen Products, LP | 1 | $99 |
| GSK | 6 | $95 |
| Xeris Pharmaceuticals, Inc. | 4 | $86 |
| Exact Sciences | 4 | $77 |
| Bayer | 3 | $60 |
| Almatica Pharma LLC | 2 | $48 |
| Amgen | 3 | $45 |
| EMD Serono, Inc. | 2 | $40 |
| Verona Pharma, Inc. | 2 | $38 |
| Global Blood Therapeutics, Inc. | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| Lilly USA, LLC | 2 | $30 |
| Hologic Sales And Service, LLC | 1 | $22 |
| Novartis | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Boehringer Ingelheim | 1 | $17 |
| Pfizer | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,980 in reported general payments places this provider in the 95th percentile of 4,941 family providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 203 | $884,568 |
| OdefseyEmtricitab/Rilpiviri/Tenof Ala | 44 | $171,094 |
| SymtuzaDarunavir/Cob/Emtri/Tenof Alaf | 23 | $124,922 |
| GenvoyaElviteg/Cob/Emtri/Tenof Alafen | 23 | $92,531 |
| DovatoDolutegravir Sodium/Lamivudine | 24 | $77,045 |
| RybelsusSemaglutide | 45 | $66,183 |
| OzempicSemaglutide | 57 | $53,965 |
| TriumeqAbacavir/Dolutegravir/Lamivudi | 13 | $47,935 |
| Invega SustennaPaliperidone Palmitate | 14 | $35,066 |
| IsentressRaltegravir Potassium | 14 | $25,796 |
| SymbicortBudesonide/Formoterol Fumarate | 12 | $3,667 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 24 | $3,604 |
| Rosuvastatin Calcium | 122 | $1,427 |
| Emtricitabine-Tenofovir DisopEmtricitabine/Tenofovir (Tdf) | 13 | $1,376 |
| Amlodipine Besylate | 271 | $1,311 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy, Genvoya | $2,029 | $977,099226 claims |
| Viiv Healthcare CompanyDovato, Triumeq | $3,651 | $124,97937 claims |
| Janssen Products, LPSymtuza | $99 | $124,92223 claims |
| Novo NordiskRybelsus, Ozempic | $707 | $120,147102 claims |
| Johnson & JohnsonInvega Sustenna | $1,505 | $35,06614 claims |
| MerckIsentress | $570 | $25,79614 claims |
| AstraZenecaSymbicort | $100 | $3,66712 claims |
| Almatica Pharma LLCSertraline Hcl | $48 | $22125 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,941 family providers in Illinois.
Other family in Belleville
- Amy BruggemannBelleville$88K
- Ruth CarricoChicago$582K
- Aleksandra BielawiecBarrington$373K
- Erin SieberNaperville$334K
- Jamie BroganChicago$282K
- Ashley NoethGlen Carbon$271K
- Marita KametasChicago$259K
- Shammona ClarkChicago$247K
- Amanda McKeeMount Vernon$242K
- Brooke KennardBloomington$208K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.